ADJUVANT TREATMENT WITH LEVAMISOLE IN CANCER - REVIEW OF EXPERIMENTAL AND CLINICAL DATA

被引：67

作者：

AMERY, WK

SPREAFICO, F

ROJAS, AF

DENISSEN, E

CHIRIGOS, MA

机构：

[1] JANSSEN PHARM,B-2340 BEERSE,BELGIUM

[2] IST RIC FARMACOL MARIO NEGRI,I-20157 MILAN,ITALY

[3] INST ONCOL ANGEL H ROFFO,BUENOS AIRES,ARGENTINA

[4] NIH,VIRAL BIOL BRANCH,BETHESDA,MD 20014

来源：

CANCER TREATMENT REVIEWS | 1977年 / 4卷 / 03期

关键词：

D O I：

10.1016/S0305-7372(77)80023-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：167 / 194

页数：28

共 200 条

[1]

ALEXANDER P, 1975, IMMUNOLOGICAL ASPECT

[2]

AMBRUS JL, 1975, J MED, V6, P61

[3] DOUBLE-BLIND LEVAMISOLE TRIAL IN RESECTABLE LUNG-CANCER [J].

AMERY, WK .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 277 (SEP20) :260-268

[4]

AMERY WK, 1977, IMMUNOTHERAPY CANCER

[5]

AMERY WL, 1976, CHEMOTHERAPY, V8, P275

[6]

AMIEL JL, 1969, REV FR ETUD CLIN BIO, V14, P685

[7]

ANACLERIO A, TO BE PUBLISHED

[8]

ANDERSON R, 1976, J IMMUNOL, V117, P428

[9] INFECTIOUS COMPLICATIONS OF NEOPLASTIC DISEASE [J].

ARMSTRONG, D ;

YOUNG, LS ;

MEYER, RD ;

BLEVINS, AH .

MEDICAL CLINICS OF NORTH AMERICA, 1971, 55 (03) :729-+

[10]

BANSAL SC, 1974, ISRAEL J MED SCI, V10, P939

← 1 2 3 4 5 6 7 8 9 10 →